Assay of glioma cell responses to an anticancer drug in a cell-based microfluidic device

Microfluidics and Nanofluidics

Volumn 9, Issue 4-5, 2010, Pages 717-725

  Liu, Wenming ^a   Sun, Peng ^a   Yang, Linyan ^a   Wang, Jinfeng ^a   Li, Li ^a   Wang, Jinyi ^a  

^a NORTHWEST A F UNIVERSITY   (China)

Author keywords

Anticancer drug; Cell culture; Cell based assay; Cellular response; Microfluidic device

Indexed keywords

ANTICANCER DRUG; BRAIN TUMOURS; CELL VIABILITY; CELL-BASED; CELL-BASED ASSAY; CELLULAR RESPONSE; EFFECTIVE TOOL; GLIOMA CELLS; IN-CELL; IN-VITRO; MICRO-FLUIDIC DEVICES; MICROFLUIDIC DEVICE; PROPIDIUM IODIDE; RESEARCH METHODS; TEMPORAL CHANGE;

FLUIDIC DEVICES; MICROFLUIDICS; RESEARCH; TELEMETERING;

CELL CULTURE;

EID: 77957585276     PISSN: 16134982     EISSN: 16134990     Source Type: Journal    
DOI: 10.1007/s10404-010-0584-5     Document Type: Article

References (33)

1. Aschhoff B (2000) Retrospective study of Ukrain treatment in 203 patients with advanced-stage tumors. Drugs Exp Clin Res 26:249-252
2. Barbee KA (2005) Mechanical cell injury. Ann N Y Acad Sci 1066: 67-84. doi:10.1196/annals.1363.006
3. Burg MB, Ferraris JD, Dmitrieva NI (2007) Cellular response to hyperosmotic stresses. Physiol Rev 87:1441-1474. doi:10.1152/ physrev.00056.2006
4. Daniel KD, Kim GY, Vassiliou CC, Jalali-Yazdi F, Langer R, Cima MJ (2007) Multi-reservoir device for detecting a soluble cancer biomarke. Lab Chip 7:1288-1293. doi:10.1039/b705143c (Pubitemid 47482974)
5. Gómez-Sjöberg R, Leyrat AA, Pirone DM, Chen CS, Quake SR (2007) Versatile, fully automated, microfluidic cell culture system. Anal Chem 79:8557-8563. doi:10.1021/ac071311w (Pubitemid 350171363)
6. Grobben B, De Deyn PP, Slegers H (2002) Rat C6 glioma as experimental model system for the study of glioblastoma growth and invasion. Cell Tissue Res 310:257-270. doi:10.1007/s00441-002-0651-7 (Pubitemid 35435769)
7. Gromeier M, Wimmer E (2001) Viruses for the treatment of malignant glioma. Curr Opin Mol Ther 3:503-508
8. Guchelaar H, Vermes I, Koopmans RP, Reutelingsperger CPM, Haanen C (1998) Apoptosis- and necrosis-inducing potential of cladribine, cytarabine, cisplatin, and 5-fuorouracil in vitro: a quantitative pharmacodynamic model. Cancer Chemother Pharmacol 42:77-83. doi:10.1007/s002800050788 (Pubitemid 28224995)
9. Hess KR, Broglio KR, Bondy ML (2004) Adult glioma incidence trends in the United States, 1977-2000. Cancer 101:2293-2299. doi:10.1002/cncr.20621 (Pubitemid 39458686)
10. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ (2008) Cancer statistics, 2008. CA Cancer J Clin 58:71-96. doi: 10.3322/ca.2007.0010 (Pubitemid 351521864)
11. Komen J, Wolbers F, Franke HR, Andersson H, Vermes I, van den Berg A (2008) Viability analysis and apoptosis induction of breast cancer cells in a microfluidic device: effect of cytostatic drugs. Biomed Microdevices 10:727-737. doi:10.1007/s10544-008-9184-5
12. Kristensen BW, Noer H, Gramsbergen JB, Zimmer J, Noraberg J (2003) Colchicine induces apoptosis in organotypic hippocampal slice cultures. Brain Res 964:264-278. doi:10.1016/S0006-8993(02)04080-5 (Pubitemid 36165151)
13. Legler JM, Gloeckler Ries LA, Smith MA, Warren JL, Heineman EF, Kaplan RS, Linet MS (1999) Brain and other central nervous system cancers: recent trends in incidence and mortality. J Natl Cancer Inst 91:1382-1390
14. Ma B, Zhang G, Qin J, Lin B (2009) Characterization of drug metabolites and cytotoxicity assay simultaneously using an integrated microfluidic device. Lab Chip 9:232-238. doi:10.1039/b809117j
15. Mazia D, Schatten G, Sale W (1975) Adhesion of cells to surfaces coated with polylysine. J Cell Biol 66:198-200
16. McDonald JC, Duffy DC, Anderson JR, Chiu DT, Wu H, Schueller OJA, Whitesides GM (2000) Fabrication of microfluidic systems in poly(dimethylsiloxane). Electrophoresis 21:27-40. doi:10.1002/(sici)1522- 2683(20000101)21
17. Nichols KE, Malkin D, Garber JE, Fraumeni JF Jr, Li FP (2001) Germ-line p53 mutations predispose to a wide spectrum of earlyonset cancers. Cancer Epidemiol Biomarkers Prev 10:83-87
18. Ohgaki H, Dessen P, Jourde B, Horstmann S, Nishikawa T, Di Patre PL, Burkhard C, Schüler D, Probst-Hensch NM, Maiorka PC, Baeza N, Pisani P, Yonekawa Y, Yasargil MG, Lütolf UM, Kleihues P (2004) Genetic pathways to glioblastoma: a population-based study. Cancer Res 64:6892-6899
19. Rainov NG, Ren H (2003) Gene therapy for human malignant brain tumors. Cancer J 9:180-188
20. Reardon DA, Rich JN, Friedman HS, Bigner DD (2006) Recent advances in the treatment of malignant astrocytoma. J Clin Oncol 24:1253-1265. doi:10.1200/jco.2005.04.5302 (Pubitemid 46622028)
21. Rees J (2008) Neurological oncology. Medicine 36:609-615. doi: 10.1383/medc.32.10.75.51497
22. Regehr KJ, Domenech M, Koepsel JT, Carver KC, Ellison-Zelski SJ, Murphy WL, Schuler LA, Alarid ET, Beebe DJ (2009) Biological implications of polydimethylsiloxane-based microfluidic cell culture. Lab Chip 9:2132-2139. doi:10.1039/b903043c
23. Stummer W, Pichlmeier U, Meinel T, Wiestler OD, Zanella F, Reulen HJ (2006) Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol 7:392-401. doi:10.1016/s1470-2045(06)70665-9
24. Takeda M, Suzuki Y, Obara N, Nagai Y (2000) Induction of apoptosis by colchicine in taste bud and epithelial cells of the mouse circumvallate papillae. Cell Tissue Res 302:391-395. doi:10.1007/s004410000294
25. Taylor AM, Blurton-Jones M, Rhee SW, Cribbs DH, Cotman CW, Jeon NL (2005) A microfluidic culture platform for CNS axonal injury, regeneration and transport. Nat Methods 2:599-605. doi:10.1038/nmeth777 (Pubitemid 41086851)
26. Thorsen T, Maerkl SJ, Quake SR (2002) Microfluidic large-scale integration. Science 298:580-584. doi:10.1126/science.1076996 (Pubitemid 35215308)
27. Walsh CL, Babin BM, Kasinskas RW, Foster JA, McGarry MJ, Forbes NS (2009) A multipurpose microfluidic device designed to mimic microenvironment gradients and develop targeted cancer therapeutics. Lab Chip 9:545-554. doi:10.1039/b810571e
28. Wang J, Ren L, Li L, Liu W, Zhou J, Yu W, Tong D, Chen S (2009) Microfluidics: a new cosset for neurobiology. Lab Chip 9:644-652. doi:10.1039/b813495b
29. Whitesides GM (2006) The origins and the future of microfluidics. Nature 442:368-373. doi:10.1038/nature05058 (Pubitemid 44264779)
30. Wong ET, Brem S (2007) Taming glioblastoma: targeting angiogenesis. J Clin Oncol 25:4705-4706. doi:10.1200/jco.2007.13.1037 (Pubitemid 350086470)
31. Wrensch M, Minn Y, Chew T, Bondy M, Berger MS (2002) Epidemiology of primary brain tumors: current concepts and review of the literature. Neuro Oncol 4:278-299. doi:10.1215/15228517-4-4-278
32. Wu LY, Carlo DD, Lee LP (2008) Microfluidic self-assembly of tumor spheroids for anticancer drug discovery. Biomed Microdevices 10:197-202. doi:10.1007/s10544-007-9125-8 (Pubitemid 351337922)
33. Ye N, Qin J, Liu X, Shi W, Lin B (2007) Characterizing doxorubicininduced apoptosis in HepG2 cells using an integrated microfluidic device. Electrophoresis 28:1146-1153. doi:10.1002/elps.200600450 (Pubitemid 46592912)